| Disease Info Index | ||||||||||||||||||||||||||
|
|
|
|
|
Text
|
2011 Dec 2 Analysis of costs of transrectal prostate biopsy. Fandella A Divisione urologica, Casa di Cura Giovanni XXIII Monastier (Treviso) - Italy. Introduction. Literature reports mortality and morbidity data from prostatic carcinoma which permit a better use of some routine diagnostic tools such... Read More Source: PubMed 2011 Dec 2 Analysis of costs of transrectal prostate biopsy. Fandella A Divisione urologica, Casa di Cura Giovanni XXIII Monastier (Treviso) - Italy. Introduction. Literature reports mortality and morbidity data from prostatic carcinoma which permit a better use of some routine diagnostic tools such... Read More Source: PubMed 2011 Dec 5 Benign Ganglion Cells "Invasion" in Prostate Needle Biopsy. Rossi G, Mengoli MC, Cadioli A, Cavazza A Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy. ... Read More Source: PubMed Prague Med Rep Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer. Sfoungaristos S, Perimenis P Department of Urology, University Hospital of Patras, Patras, Greece. To evaluate the potential role of several clinical and pathological parameters in prediction of seminal vesicle invasion in patients with cl... Read More Source: PubMed BJU Int. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. Cohen RJ, O'Brien BA Uropath Pty Ltd and School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia. ... Read More Source: PubMed Characterization of KRAS Rearrangements in Metastatic Prostate Cancer. Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X, Robinson D, Cao Q, Prensner JR, Yocum AK, Wang R, Fries DF, Han B, Asangani IA, Cao X, Li Y, Omenn GS, Pflueger D, Gopalan A, Reuter VE, Kahoud ER, Cantley LC, Rubin MA, Palanisamy N, Varambally S, Chinnaiyan AM Michigan Center for Translational Pathology, Ann Arbor, MI, 48109, USA. Using an integrative genomics approach called Amplification Breakpoint Ranking and Assembly (ABRA) analysis, we nominated KRAS as a gene fusion with t... Read More Source: PubMed 2011 Nov 23 [Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor.] Finamanti M, Antonelli A, Contessa P, Cosciani Cunico S, Simeone C Unitŕ operativa di Urologia, Spedali Civili di Brescia, Universitŕ degli Studi di Brescia, Brescia - Italy. Prostate cancer is a disease with a variable clinical course. The possible impact on oncological outcome of non-acinar prostate cancer has not been es... Read More Source: PubMed 2011 Nov 25 Age: "a natural anesthetic" in pain perception during the transrectal ultrasound-guided prostate biopsy procedure. Dell'atti L, Borea PA, Russo GR 1 Urology Unit, Arcispedale "S. Anna", Ferrara, Italy. Introduction. The purpose of this study was to evaluate how the age factor might influence the tolerance biopsy examination, and then choose the modal... Read More Source: PubMed 2011 Dec 5 Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer Among High-Risk Men Enrolled in Prostate Cancer Early Detection. Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN 1Cancer Prevention and Control, Fox Chase Cancer Center. BACKGROUND: Men with familial prostate cancer (PCA) and African American men are at risk for developing PCA at younger ages. Genetic markers predictin... Read More Source: PubMed 2011 Dec 5 Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Chakroborty D, Sarkar C, Yu H, Wang J, Liu Z, Dasgupta PS, Basu S Department of Pathology, Ohio State University, Columbus, OH 43210. Impaired blood flow in the tumor vascular bed caused by structurally and functionally abnormal blood vessels not only hinders the delivery of chemothe... Read More Source: PubMed 2011 Dec 6 Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme. Nomura M, Ito K, Miyakubo M, Sekine Y, Tamura Y, Shimizu N, Aoki S, Suzuki K Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan. Background:We previously reported the diagnostic efficacy of the age- and prostate volume-adjusted prostate biopsy method (the adjusted biopsy method)... Read More Source: PubMed 2011 Dec 5 Benign Ganglion Cells "Invasion" in Prostate Needle Biopsy. Rossi G, Mengoli MC, Cadioli A, Cavazza A Azienda Ospedaliero-Universitaria Policlinico of Modena, Modena, Italy. ... Read More Source: PubMed Prague Med Rep Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer. Sfoungaristos S, Perimenis P Department of Urology, University Hospital of Patras, Patras, Greece. To evaluate the potential role of several clinical and pathological parameters in prediction of seminal vesicle invasion in patients with cl... Read More Source: PubMed BJU Int. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer. Cohen RJ, O'Brien BA Uropath Pty Ltd and School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia. ... Read More Source: PubMed Characterization of KRAS Rearrangements in Metastatic Prostate Cancer. Wang XS, Shankar S, Dhanasekaran SM, Ateeq B, Sasaki AT, Jing X, Robinson D, Cao Q, Prensner JR, Yocum AK, Wang R, Fries DF, Han B, Asangani IA, Cao X, Li Y, Omenn GS, Pflueger D, Gopalan A, Reuter VE, Kahoud ER, Cantley LC, Rubin MA, Palanisamy N, Varambally S, Chinnaiyan AM Michigan Center for Translational Pathology, Ann Arbor, MI, 48109, USA. Using an integrative genomics approach called Amplification Breakpoint Ranking and Assembly (ABRA) analysis, we nominated KRAS as a gene fusion with t... Read More Source: PubMed 2011 Nov 23 [Ductal carcinoma of the prostate: impact on survival and therapeutic controversies of a rare tumor.] Finamanti M, Antonelli A, Contessa P, Cosciani Cunico S, Simeone C Unitŕ operativa di Urologia, Spedali Civili di Brescia, Universitŕ degli Studi di Brescia, Brescia - Italy. Prostate cancer is a disease with a variable clinical course. The possible impact on oncological outcome of non-acinar prostate cancer has not been es... Read More Source: PubMed 2011 Nov 25 Age: "a natural anesthetic" in pain perception during the transrectal ultrasound-guided prostate biopsy procedure. Dell'atti L, Borea PA, Russo GR 1 Urology Unit, Arcispedale "S. Anna", Ferrara, Italy. Introduction. The purpose of this study was to evaluate how the age factor might influence the tolerance biopsy examination, and then choose the modal... Read More Source: PubMed 2011 Dec 5 Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer Among High-Risk Men Enrolled in Prostate Cancer Early Detection. Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN 1Cancer Prevention and Control, Fox Chase Cancer Center. BACKGROUND: Men with familial prostate cancer (PCA) and African American men are at risk for developing PCA at younger ages. Genetic markers predictin... Read More Source: PubMed 2011 Dec 5 Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Chakroborty D, Sarkar C, Yu H, Wang J, Liu Z, Dasgupta PS, Basu S Department of Pathology, Ohio State University, Columbus, OH 43210. Impaired blood flow in the tumor vascular bed caused by structurally and functionally abnormal blood vessels not only hinders the delivery of chemothe... Read More Source: PubMed 2011 Dec 6 Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme. Nomura M, Ito K, Miyakubo M, Sekine Y, Tamura Y, Shimizu N, Aoki S, Suzuki K Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan. Background:We previously reported the diagnostic efficacy of the age- and prostate volume-adjusted prostate biopsy method (the adjusted biopsy method)... Read More Source: PubMed |
| Share it! |
|
|
|
|




|
Posted by:
binary(Guest)
Posted on: 07/25/2011 Well I won't be doing that again! Had transrectal prostate biopsy on Monday, by Wed evening was in hospital with blood infection and also severely painful infection in right testicle. Took three days of antibiotics to get rid of the infection and fever, but I'm told the testicle [swollen to three times normal] will take weeks to return to normal size. No one saying anything about whether it will still work or not.
Lovely.
Reply |
Forward
|
| Citing this Health Article | ||||||
|
||||||
| News on Prostate Biopsy |
|
Radiation Exposure Reduced by Lower Dosage CT-Guided Lung Biopsy Protocol |
|
Robotic Surgery to Remove Prostate Gland |
|
Research Indicates Surgical Breast Biopsy is Not Overused |
|
Consistency Observed in Biopsy Referral After PSA Screening |
|
Biopsy of Recurrent Breast Cancer Could Modify Treatment |
| Total News Item 42 | |